Literature DB >> 2789500

Serum osteocalcin concentrations in patients with rheumatoid arthritis.

P Pietschmann1, K P Machold, W Wolosczuk, J S Smolen.   

Abstract

Osteocalcin is a non-collagenous bone matrix protein which is released into the circulation and can be measured by radioimmunoassay. Recent studies indicate that serum osteocalcin concentrations are a marker of bone formation. Because bone demineralisation is a common finding in patients with rheumatoid arthritis (RA) the serum osteocalcin concentrations and, in addition, the serum concentrations of 25-hydroxyvitamin D, parathyroid hormone, and calcitonin were measured in 29 patients with RA and in 30 control subjects. Whereas serum osteocalcin concentrations were similar in patients with RA and in control subjects, serum 25-hydroxyvitamin D concentrations were significantly decreased in patients with RA. Serum concentrations of parathyroid hormone and calcitonin in patients with RA and in control subjects were not statistically different. The normal osteocalcin concentrations in patients with RA suggest a normal rate of bone formation in these patients.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2789500      PMCID: PMC1003841          DOI: 10.1136/ard.48.8.654

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  20 in total

1.  1958 Revision of diagnostic criteria for rheumatoid arthritis.

Authors:  M W ROPES; G A BENNETT; S COBB; R JACOX; R A JESSAR
Journal:  Bull Rheum Dis       Date:  1958-12

2.  Physical activity, cystic erosions, and osteoporosis in rheumatoid arthritis.

Authors:  B A Castillo; R A el Sallab; J T Scott
Journal:  Ann Rheum Dis       Date:  1965-11       Impact factor: 19.103

3.  Origin of the vitamin K-dependent bone protein found in plasma and its clearance by kidney and bone.

Authors:  P A Price; M K Williamson; J W Lothringer
Journal:  J Biol Chem       Date:  1981-12-25       Impact factor: 5.157

4.  Comparison of serum 1,25-dihydroxycholecalciferol concentrations in rheumatoid arthritis and osteoarthrosis.

Authors:  H A Bird; V Wright; U Hennes; E Theiss
Journal:  Ann Rheum Dis       Date:  1982-06       Impact factor: 19.103

5.  Prevalence of decreased bone mass in rheumatoid arthritis. Relation to anti-inflammatory treatment.

Authors:  O S Als; C Christiansen; C Hellesen
Journal:  Clin Rheumatol       Date:  1984-06       Impact factor: 2.980

6.  Osteomalacia in rheumatoid arthritis.

Authors:  S O'Driscoll; M O'Driscoll
Journal:  Ann Rheum Dis       Date:  1980-02       Impact factor: 19.103

7.  Serum bone Gla-protein: a specific marker for bone formation in postmenopausal osteoporosis.

Authors:  J P Brown; P D Delmas; L Malaval; C Edouard; M C Chapuy; P J Meunier
Journal:  Lancet       Date:  1984-05-19       Impact factor: 79.321

8.  Metabolic bone disease among in-patients with rheumatoid arthritis.

Authors:  B P Wordsworth; S Vipond; C G Woods; A G Mowat
Journal:  Br J Rheumatol       Date:  1984-11

9.  New biochemical marker for bone metabolism. Measurement by radioimmunoassay of bone GLA protein in the plasma of normal subjects and patients with bone disease.

Authors:  P A Price; J G Parthemore; L J Deftos
Journal:  J Clin Invest       Date:  1980-11       Impact factor: 14.808

10.  Total body calcium in rheumatoid arthritis: effects of disease activity and corticosteroid treatment.

Authors:  D M Reid; N S Kennedy; M A Smith; P Tothill; G Nuki
Journal:  Br Med J (Clin Res Ed)       Date:  1982-07-31
View more
  8 in total

1.  Serum osteocalcin concentrations in patients with rheumatoid arthritis.

Authors:  D Vanderschueren
Journal:  Ann Rheum Dis       Date:  1990-04       Impact factor: 19.103

2.  The time of blood sampling for osteocalcin determinations.

Authors:  J M Nolla; A Rozadilla
Journal:  Ann Rheum Dis       Date:  1990-02       Impact factor: 19.103

3.  Serum osteocalcin and carboxyterminal propeptide of type I procollagen in rheumatoid arthritis.

Authors:  H Kröger; J Risteli; L Risteli; I Penttilä; E Alhava
Journal:  Ann Rheum Dis       Date:  1993-05       Impact factor: 19.103

4.  Effect of calcitonin on bone histomorphometry and bone metabolism in rheumatoid arthritis.

Authors:  H Kröger; I Arnala; E M Alhava
Journal:  Calcif Tissue Int       Date:  1992-01       Impact factor: 4.333

5.  Osteoporosis in rheumatoid arthritis: effect of disease activity.

Authors:  R Celiker; Y Gökçe-Kutsal; A Cindas; M Ariyürek; N Renda; Z Koray; O Basgöze
Journal:  Clin Rheumatol       Date:  1995-07       Impact factor: 2.980

6.  Osteocalcin in patients with rheumatoid arthritis--effect of anatomical stages, inflammatory activity and therapy.

Authors:  H Franck; T H Ittel; O Tasch; G Herborn; R Rau
Journal:  Rheumatol Int       Date:  1992       Impact factor: 2.631

Review 7.  Interaction of the endocrine system with inflammation: a function of energy and volume regulation.

Authors:  Rainer H Straub
Journal:  Arthritis Res Ther       Date:  2014-02-13       Impact factor: 5.156

Review 8.  Bone phenotypes in rheumatology - there is more to bone than just bone.

Authors:  Christian S Thudium; Signe Holm Nielsen; Samra Sardar; Ali Mobasheri; Willem Evert van Spil; Rik Lories; Kim Henriksen; Anne-Christine Bay-Jensen; Morten A Karsdal
Journal:  BMC Musculoskelet Disord       Date:  2020-11-28       Impact factor: 2.362

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.